gsk glp 1 agonist Emerging Trends in the Development of GLP-1 Receptor Agonists GLP-1 Receptor Agonists: The New
Description
Whole-cell patch clamp analysis showed that glutamate-induced currents and voltage-dependent calcium channel currents were significantly reduced in GLP-1-pre-treated neurons
A previous CB1 receptor blocker, Rimonabant, was approved in Europe in 2006 but was discontinued in 2008 owing to serious psychiatric side effects
Goodwin Cartwright, C
Grams, M
Alzheimers disease drug development pipeline: 2024
